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Parkinson's disease (PD), the secondmost common neurodegenerative
disorder, affects roughly 7–10 million people worldwide. A wide array
of research has suggested that PD has a mitochondrial component and
that mitochondrial dysfunction occurs well in advance of the clinical
manifestation of the disease. Previous work by our lab has categorized
the mitochondrial disorder associated with Parkinson's disease in a
PINK1 knockout rat model. This model develops Parkinson's disease in
a spontaneous, predictable manner. Our ﬁndings demonstrated
PINK1-deﬁcient rats at 4 months of age had mitochondrial proteomic
and functional abnormalities before the onset of Parkinsonian symp-
toms (6 months) such as the movement disorder, loss of midbrain
dopaminergic neurons, or the progressive degeneration present at
9 months. With this in mind, our group investigated the PINK1
knockout genetic rat model at postnatal day 10 to determine if the
observed alterations at 4 months were present at an earlier time point.
Using a proteomic analysis of brain mitochondria, we identiﬁed sig-
niﬁcant mitochondrial proteomic alterations in the absence of mito-
chondrial functional changes suggesting the observed alterations are
part of the mitochondrial pathways leading to PD. Speciﬁcally, we
identiﬁed differentially expressed proteins in the PINK1 knockout rat
involved in glycolysis, the tricarboxylic acid cycle, and fatty acid
metabolism demonstrating abnormalities occur well in advance of the
manifestation of clinical symptoms. Additionally, 13 of the differen-
tially expressed proteins have been previously identiﬁed in olderis an open access article under the CC BY license
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L.M. Villeneuve et al. / Data in Brief 6 (2016) 428–432 429PINK1 knockout animals as differentially regulated suggesting these
proteins may be viable markers of the PD pathology, and further, the
abnormally regulated pathways could be targeted for therapeutic
interventions. All raw data can be found in Supplementary Table 1.
& 2015 Published by Elsevier Inc. This is an open access article under
the CC BY license (http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Biology
ore speciﬁc sub-
ject areaNeurobiologyype of data Protein expression table
ow data was
acquiredSWATH mass spectrometry (AB Sciex Triple-TOF 5600)ata format Normalized data
xperimental
factorsGenetic ablation of the Pink1 (A Parkinson's disease model)xperimental
featuresBrains were isolated from post-natal day 10 (P10) males and age-matched
controls (n¼4). Mitochondria were isolated by a dual, sequential isolation
and the resulting proteins were obtained for mass spectrometry.ata source
locationOmaha, NEata accessibility The SWATH-MS data for the mitochondria isolated from the 10 day old PINK1
KO rat model can be accessed as Supplementary Table 1.Value of the data These methods demonstrate the ability to reproducibly quantify the brain mitochondrial proteome
of animals at an early stage in life.
 These data provide differential expression changes in proteins known to directly inﬂuence mito-
chondrial function.
 These data suggest, when compared against previous studies, the fatty acid metabolic pathway is
constitutively altered in a Parkinson's disease model and merits further investigation.1. Data
Comparative analysis of the brain proteome of 10 day old PINK1 knockout animals revealed
directed proteomic alterations present in the fatty acid metabolic pathway with signiﬁcant expression
deﬁcits in 3-keto-CoA thiolase A (Acaa1a), 3-ketoacyl-CoA thiolase (mitochondrial) (Acaa2), and
electron transfer ﬂavoprotein subunit beta (Etfb). The rate-limiting enzyme of the citric acid cycle,
isocitrate dehydrogenase (Idh1) was found to be signiﬁcantly depressed and a key enzyme of gly-
colysis, fructose-bisphophate aldolase A (Aldoa) was decreased. When these data were compared
against data obtained from older animals [1], similar expression proﬁles alterations were identiﬁed (
Table 1). In conjunction with other previously published data, these data suggest identify PINK1
pathways that are constitutively altered in Parkinson's disease.
Table 1
List of signiﬁcantly altered proteins in 10 day old PINK1 KO rats compared with expression at 4 and 9 months of age. Proteins identiﬁed as signiﬁcantly altered in PINK1 KO rats at 10 days of
age were compared against data from 4 and 9 month old animals [1]. Only proteins listed as signiﬁcantly different in 2 (10 day and 4 month or 9 month) analyses were included. For all
proteins, a Bayesian analysis was performed with the Bayesian coefﬁcient¼12. Multiple testing corrections were applied in the form of cumulative posterior probability of differential
expression (Cum. PPDE). Proteins were listed as signiﬁcantly different if po0.05 and Cum. PPDEZ0.95. Protein expression values listed are log2 (PINK1 KO/LEH). Unlisted values denote
proteins without sufﬁcient conﬁdence for quantiﬁcation. Values highlighted in green or red showed signiﬁcantly decreased or increased expression in PINK1 KO rats, respectively.
Uniprot Protein Gene 10 day
(Log2
PINK1
KO/
LEH)
p-value PPDE Cortex Striatum
4 month
(Log2
PINK1
KO/LEH)
p-value PPDE 9 month
(Log2
PINK1
KO/LEH)
p-value PPDE 4 month
(Log2
PINK1
KO/LEH)
p-value PPDE 9 month
(Log2
PINK1
KO/LEH)
p-value PPDE
P21775 3-ketoacyl-CoA
thiolase A,
peroxisomal
Acaa1a 1.21 1.93E06 1.00 1.03 2.50E04 0.98 0.44 4.32E01 0.00 0.29 6.22E01 0.41
P13437 3-ketoacyl-CoA
thiolase,
mitochondrial
Acaa2 0.47 8.66E05 0.99 0.45 1.90E04 0.99 1.07 2.17E02 0.00 0.68 7.99E04 0.95 0.37 2.74E01 0.59
Q68FU3 Electron transfer
ﬂavoprotein subunit
beta
Etfb 0.57 1.44E04 0.99 0.60 5.12E05 0.99 0.14 7.41E01 0.00 1.00 2.78E06 1.00 1.20 8.79E03 0.89
P05065 Fructose-bispho-
sphate aldolase A
Aldoa 0.88 6.08E08 1.00 1.20 5.86E12 1.00 0.84 1.18E02 0.00 1.38 5.55E08 1.00 0.98 1.57E02 0.86
P08753 Guanine nucleo-
tide-binding pro-
tein G(k) subunit
alpha
Gnai3 0.82 1.15E09 1.00 0.66 1.04E04 0.99 0.11 6.57E01 0.00 0.48 5.96E02 0.68 0.84 5.55E03 0.91
Q6P747 Heterochromatin
protein 1-binding
protein 3
Hp1bp3 0.53 8.62E04 0.95 0.52 8.23E04 0.96 0.33 2.96E01 0.00 0.55 2.22E02 0.78 0.70 1.01E01 0.73
Q00715 Histone H2B type 1 N/A 0.77 6.55E08 1.00 0.77 3.85E08 1.00 0.47 1.07E01 0.00 0.30 1.10E01 0.60 1.54 7.85E06 0.99
P62804 Histone H4 Hist1h4b 0.43 4.86E05 0.99 0.43 3.78E05 1.00 0.28 2.09E01 0.00 0.44 1.18E02 0.83 1.39 2.12E08 1.00
Q00238 Intercellular adhe-
sion molecule 1
Icam1 1.36 4.29E04 0.97 1.37 8.47E04 0.96
P41562 Isocitrate dehy-
drogenase [NADP]
cytoplasmic
Idh1 0.48 1.48E04 0.99 0.53 2.36E05 1.00 0.19 7.19E01 0.00 0.63 9.35E02 0.62 0.62 2.93E01 0.57
Q5M9G9 Protein TBRG4 Tbgr4 0.86 2.80E04 0.98 0.85 3.09E04 0.98 0.90 3.15E02 0.75
Q4FZT0 Stomatin-like pro-
tein 2,
mitochondrial
Stoml2 2.14 3.25E05 1.00 2.15 3.62E05 1.00 0.01 9.76E01 0.00 0.60 6.80E03 0.87 0.58 1.98E01 0.64
P69897 Tubulin beta-5
chain
Tubb5 0.56 1.16E06 1.00 0.39 7.32E06 1.00 0.03 8.83E01 0.00 0.29 1.67E01 0.55 0.41 2.02E01 0.64
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2.1. Animals
All animal experiments were conducted with PINK1 KO and the Long Evans Hooded (LEH) control
strains. PINK1 KO and LEH control female animals were housed together for 3 weeks to allow for
synchronization of estrous cycle. Animals were then separated by genotype and bred. Animals for all
experiments were born on the same day. All animals were 10 days old at the time of the experiments.
Only male animals were used for the experiments. Gender was initially visually assessed but con-
ﬁrmed by necropsy. All protocols were conducted within NIH-approved guidelines with the approval
and oversight of the University of Nebraska Medical Center IACUC.
2.2. Data-dependent analysis for building a library
A mitochondrial library was built as described previously [1,2]. In short, mitochondrial lysates
from B35, H19-7/IGF-IR, PC12 and RN33B cell lines were digested with trypsin, quantiﬁed, and
fractionated by isoelectric focusing. Peptides from each fraction were prepared for mass spectrometry
with Pierce C-18 PepClean Spin Columns (Thermo Fisher Scientiﬁc) in accordance with the manu-
facturer's instructions. Samples were dehydrated and resuspended in 6 μL of 0.1% formic acid for LC-
MS/MS analysis. The mitochondrial isolation, protein and peptide processing was performed twice
independently. The resulting 24 fractions of peptides were analyzed by nano-LC-MS/MS in SWATH-
MS mode on the 5600 TripleTOF instrument. The SWATH-MS acquisition was performed using the
published protocol [3]. The acquisition method was in data-dependent mode with one precursor scan
followed by fragmentation of the 50 most abundant peaks. Precursor peaks with a minimum signal
count of 100 were dynamically excluded after two selections for 6 s within a range 725 mDa. Charge
states other than 2–5 were rejected. Rolling collision energy was used. DDA ﬁles were searched in
Protein Pilot. Combined results yielded a library of spectra representing 2004 proteins identiﬁed with
high conﬁdence (FDRr5%).
2.3. Isolation of brain mitochondria for SWATH mass spectrometry and Seahorse analysis
Brains were rapidly isolated from 10 day old animals in both the PINK1 KO and LEH control groups.
The brains were isolated from the animals, and the cerebellum was removed. After extraction, brains
were immediately rinsed with ice-cold PBS to remove blood. The meninges were removed. Tissue was
chopped and homogenized using a Dounce homogenizer. Brain mitochondria were isolated using
differential centrifugation kit (Mitosciences, Eugene, OR) followed by an immunomagnetic puriﬁca-
tion using a kit with TOM-22 coupled to magnetic beads (MACS Miltenyi Biotec, Auburn, CA).
Mitochondria for SWATH-MS were lysed in 4% sodium dodecyl sulfate (SDS) and protein con-
centration was quantiﬁed using a using a Pierce 660 assay with bovine serum albumin standards
(Thermo Fisher Scientiﬁc, Rockford, IL).
2.4. Sample preparation for mass spectrometry and data-independent SWATH-MS analysis
Protein from the isolated mitochondria was digested with trypsin (Promega, Madison, WI) using
the ﬁlter aided proteome preparation technique with a 20-μm ﬁlter (Pall Corporation, Ann Arbor, MI)
as previously performed [2,4,5]. The resultant peptides were cleaned with an Oasis mixed-mode weak
cation exchange cartridge (Waters, Milford, MA). Peptides were quantiﬁed using a Nanodrop (Thermo
Fisher Scientiﬁc) in conjunction with Scopes method for protein quantitation [6].
2.5. Data-independent SWATH-MS analysis
Unfractionated samples of peptides from rat brain mitochondrial lysates were analyzed in quad-
ruplicate (four biological replicates per age group) using SWATH data-independent analysis (DIA) as
performed previously [5,7]. All of the fragment ion chromatograms were extracted and automatically
L.M. Villeneuve et al. / Data in Brief 6 (2016) 428–432432integrated with PeakView (v. 1.1.0.0). The raw peak areas as reported by PeakView were used for all
the quantiﬁcation calculations with no data processing (neither denoising nor smoothing) of any kind
applied to the extracted ion chromatograms. To calibrate retention times, synthetic peptides (Biog-
noSYS; Zurich, Switzerland) were spiked-in the samples in accordance with the manufacturer's
protocol. In accordance with previously published work [3], we selected 5 peptides and 5 transitions
option for quantitative analysis and targeted data extraction for each peptide was performed. Samples
were normalized to the area counts of the synthetic peptides. Brieﬂy, for each peptide the fragment
ion chromatograms were extracted using the SWATH isolation window set to a width of 10 min and
50 ppm accuracy for quantiﬁcation purposes in accordance with previously established protocols [3].
2.6. Bioinformatic analysis
Signiﬁcance was assessed using CyberT (http://cybert.ics.uci.edu/) using a sliding window of 101
and a Bayesian conﬁdence coefﬁcient of 12. Proteins were denoted as signiﬁcantly altered if po0.05
and the cumulative posterior probability of differential expression (Cum. PPDE) 40.95. A functional
association protein network was generated using STRING (Version 10; http://string-db.org/) and
uploaded into Cytoscape (Version 3.2.1) to create an interactive network [8]. Largely of 12 proteins
differentially expressed a group of 3 were involved in fatty acid metabolism while another group was
composed of histones interacting with the mitochondria. To assess the isolation of mitochondrial
proteins, MitoMiner was utilized (http://mitominer.mrc-mbu.cam.ac.uk/release-3.1/begin.do) [9].Funding
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Supplementary data associated with this article can be found in the online version at http://dx.doi.
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